Ahmed青光眼阀植入术治疗有视功能的新生血管性青光眼

Ahmed glaucoma valve implantation for those with visual function in neovascular glaucoma

目的 评价 Ahemd青光眼阀植入术治疗有视功能的新生血管性青光眼的疗效及安全性。方法 对 2 6例 2 6眼有视功能的新生血管性青光眼施行颞上象限到赤道部区域的 Ahem d青光眼阀植入术。结果 术后经 4～ 2 6 m o(平均8mo)的随访观察 ,2 2例视力提高或不变 ,占 86 .4% ,无 1例因手术而失明 ;17眼眼压控制在 0 .8～ 2 .8k Pa,眼压控制率为 6 5 .4% .术后并发症包括 :短暂性前房出血 ,术后早期低眼压 ,引流管口阻塞及植入盘脱出。结论 Ahemd青光眼阀植入术治疗有视功能的新生血管性青光眼是一种有效且安全的方法。

Objective To investigate the efficacy and security of the treatment for the with visual function in neovascular glaucoma with Ahmed glaucoma value(AGV ).Methods Twenty six cases (26 eyes) with visual function in neovascular glaucoma underwent AGV implantation Results After surgery,the follow up periods lasted for 4 to 26 months (mean 8 months ),the visual acuity of 22 eyes (86 4%) was improved or remained the same,no case of the blindness was found The mean intraocular pressure was between 0 8~2 8kPa in 17 eyes,and the Yate of control reaches to 65 4% , the postoperative complication included transicent hyphema, Early hypotony, obstruction of the tube tip and drop out of the plate Conclusion The AGV implantation treating those with visual function in neovascular glaucoma is an effective and safe method